Clinical Trials Browser

Terminated × INDUSTRY × Tumor Lysis Syndrome × Clear all

NCT04214093 2023-08-02

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Phase 1 Terminated

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Recurrence, Tumor Lysis Syndrome, Hematologic Neoplasms

NCT01097369 2013-01-31

Elitek (Rasburicase) Immuno-Monitoring Study

Tumor Lysis Syndrome